Many patients find that liquid nutrition is easier to tolerate than solid food, especially during the initial weeks of treatment
The other FDA-approved GLP-1 RA, liraglutide 3 mg [Saxenda], is administered daily and has lower efficacy than semaglutide for weight loss
This website is for educational and general wellness information purposes only and is not intended to diagnose, treat, cure, or prevent any disease or condition
800 Scudders Mill Road Plainsboro, NJ 08536 1-888-693-6742 OZEMPIC and NovoFine are registered trademarks of Novo Nordisk A/S
Share these with your provider to evaluate the effectiveness of your dose and schedule
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes